Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood.

MLA

Gorczyca, Monika E., et al. “Inhibition of Tissue Factor Pathway Inhibitor (TFPI) by ARC19499 Improves Clotting of Hemophiliac Blood.” BMC Pharmacology, vol. 10, Jan. 2010, p. 1. EBSCOhost, https://doi.org/10.1186/1471-2210-10-S1-A44.

APA

Gorczyca, M. E., Jilma, B., Male, C., Reitter, S., Gilbert, J. C., & Pabinger, I. (2010). Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood. BMC Pharmacology, 10, 1. https://doi.org/10.1186/1471-2210-10-S1-A44

Chicago

Gorczyca, Monika E., Bernd Jilma, Christoph Male, Sylvia Reitter, James C. Gilbert, and Ingrid Pabinger. 2010. “Inhibition of Tissue Factor Pathway Inhibitor (TFPI) by ARC19499 Improves Clotting of Hemophiliac Blood.” BMC Pharmacology 10 (January): 1. doi:10.1186/1471-2210-10-S1-A44.